Trials / Unknown
UnknownNCT02905916
The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 217 (estimated)
- Sponsor
- Peking University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the trail is to evaluate the efficacy and safety of PEG-rhG-CSF in primary prophylaxis and secondary prophylaxis of neutropenia after chemotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PEG-rhG-CSF |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2018-06-01
- First posted
- 2016-09-19
- Last updated
- 2016-09-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02905916. Inclusion in this directory is not an endorsement.